|
🐜
|
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
32 auth.
B. D. de Pauw,
Thomas J. Walsh,
J. P. Donnelly,
David A. Stevens,
John E. Edwards,
T. Calandra,
Peter G Pappas,
J. Maertens,
O. Lortholary,
Carol A. Kauffman,
D. W. Denning,
Thomas F. Patterson,
G. Maschmeyer,
J. Billé,
W. Dismukes,
...
R. Herbrecht,
William W. Hope,
C. Kibbler,
B. Kullberg,
K. Marr,
P. Muñoz,
F. Odds,
J. Perfect,
Á. Restrepo,
M. Ruhnke,
B. Segal,
Jack D. Sobel,
Tania C. Sorrell,
C. Viscoli,
J. Wingard,
T. Zaoutis,
John E. Bennett
|
12 |
2008 |
12
🐜
|
|
🦁
|
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
15 auth.
J. Perfect,
W. Dismukes,
F. Dromer,
D. Goldman,
J. Graybill,
R. Hamill,
T. Harrison,
R. Larsen,
O. Lortholary,
M. Nguyen,
...
P. Pappas,
W. Powderly,
Nina Singh,
J. Sobel,
T. Sorrell
|
11 |
2010 |
11
🦁
|
|
🐜
|
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
65 auth.
J. Donnelly,
S. Chen,
C. Kauffman,
W. Steinbach,
J. Baddley,
P. Verweij,
C. Clancy,
J. Wingard,
S. Lockhart,
A. Groll,
T. Sorrell,
M. Bassetti,
H. Akan,
B. Alexander,
D. Andes,
...
É. Azoulay,
R. Bialek,
R. Bradsher,
S. Bretagne,
T. Calandra,
A. Caliendo,
E. Castagnola,
M. Cruciani,
M. Cuenca‐Estrella,
C. Decker,
S. Desai,
B. Fisher,
T. Harrison,
C. Heussel,
H. E. Jensen,
C. Kibbler,
D. Kontoyiannis,
B. Kullberg,
K. Lagrou,
F. Lamoth,
T. Lehrnbecher,
Jurgen Loeffler,
O. Lortholary,
J. Maertens,
O. Marchetti,
K. Marr,
H. Masur,
J. Meis,
C. Morrisey,
M. Nucci,
L. Ostrosky-Zeichner,
L. Pagano,
T. Patterson,
J. Perfect,
Z. Ráčil,
E. Roilides,
M. Ruhnke,
Cornelia Schaefer Prokop,
S. Shoham,
M. Slavin,
D. Stevens,
G. Thompson,
J. Vázquez,
C. Viscoli,
T. Walsh,
A. Warris,
L. Wheat,
P. L. White,
T. Zaoutis,
P. Pappas
|
10 |
2019 |
10
🐜
|
|
🐜
|
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
14 auth.
O. Cornely,
J. Maertens,
D. Winston,
J. Perfect,
A. Ullmann,
T. Walsh,
D. Helfgott,
J. Hołowiecki,
D. Stockelberg,
Y. Goh,
...
M. Petrini,
C. Hardalo,
R. Suresh,
D. Angulo-Gonzalez
|
10 |
2007 |
10
🐜
|
|
🐢
|
Comparison of caspofungin and amphotericin B for invasive candidiasis.
10 auth.
Jorge Mora-Duarte,
R. Betts,
C. Rotstein,
A. Colombo,
Luis Thompson-Moya,
Juanita M. Smietana,
...
R. Lupinacci,
C. Sable,
N. Kartsonis,
J. Perfect
|
10 |
2002 |
10
🐢
|
|
🐢
|
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
T. G. Mitchell,
J. Perfect
|
10 |
1995 |
10
🐢
|
|
🐜
|
Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
8 auth.
M. Saag,
R. Graybill,
R. Larsen,
P. Pappas,
J. Perfect,
W. Powderly,
...
J. Sobel,
W. Dismukes
|
9 |
2000 |
9
🐜
|
|
🐜
|
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
23 auth.
T. Walsh,
P. Pappas,
D. Winston,
H. Lazarus,
F. Petersen,
J. Raffalli,
S. Yanovich,
P. Stiff,
R. Greenberg,
G. Donowitz,
...
M. Schuster,
A. Reboli,
J. Wingard,
C. Arndt,
J. Reinhardt,
S. Hadley,
R. Finberg,
M. Laverdière,
J. Perfect,
G. Garber,
G. Fioritoni,
E. Anaissie,
Jeanette Y. Lee
|
9 |
2002 |
9
🐜
|
|
🐢
|
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
23 auth.
T. Walsh,
I. Raad,
T. Patterson,
P. Chandrasekar,
G. Donowitz,
R. Graybill,
R. Greene,
R. Hachem,
S. Hadley,
R. Herbrecht,
...
A. Langston,
A. Louie,
P. Ribaud,
B. Segal,
D. Stevens,
J. V. van Burik,
C. White,
G. Corcoran,
J. Gogate,
G. Krishna,
L. Pedicone,
C. Hardalo,
J. Perfect
|
9 |
2007 |
9
🐢
|
|
🐜
|
Human dectin-1 deficiency and mucocutaneous fungal infections.
25 auth.
B. Ferwerda,
G. Ferwerda,
T. Plantinga,
J. Willment,
A. V. van Spriel,
H. Venselaar,
Clara C Elbers,
Melissa D. Johnson,
A. Cambi,
Cristal Huysamen,
L. Jacobs,
Trees Jansen,
K. Verheijen,
L. Masthoff,
S. Morré,
...
G. Vriend,
David L. Williams,
J. Perfect,
L. Joosten,
C. Wijmenga,
J. V. D. van der Meer,
G. Adema,
B. Kullberg,
Gordon D. Brown,
M. Netea
|
9 |
2009 |
9
🐜
|
|
🦁
|
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
11 auth.
J. Perfect,
K. Marr,
T. Walsh,
R. Greenberg,
B. Dupont,
J. de la Torre-Cisneros,
...
G. Just-Nübling,
H. Schlamm,
I. Lutsar,
A. Espinel-Ingroff,
Elizabeth Johnson
|
9 |
2003 |
9
🦁
|
|
🐜
|
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
25 auth.
P. Koehler,
M. Bassetti,
A. Chakrabarti,
S. Chen,
S. Chen,
A. Colombo,
M. Hoenigl,
M. Hoenigl,
N. Klimko,
C. Lass‐Flörl,
R. Oladele,
D. Vinh,
Li-Ping Zhu,
B. Böll,
R. Brüggemann,
...
J. Gangneux,
J. Perfect,
T. Patterson,
T. Persigehl,
J. Meis,
J. Meis,
L. Ostrosky-Zeichner,
P. White,
P. Verweij,
O. Cornely
|
9 |
2020 |
9
🐜
|
|
🐜
|
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
12 auth.
T. Walsh,
J. Hiemenz,
N. Seibel,
J. Perfect,
G. Horwith,
Lily Lee,
...
J. Silber,
M. Dinubile,
A. Reboli,
E. Bow,
J. Lister,
E. Anaissie
|
9 |
1998 |
9
🐜
|
|
🐜
|
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.
14 auth.
P. Pappas,
J. Perfect,
G. Cloud,
R. Larsen,
G. Pankey,
D. Lancaster,
H. Henderson,
C. Kauffman,
D. Haas,
M. Saccente,
...
R. Hamill,
M. Holloway,
R. M. Warren,
W. Dismukes
|
9 |
2001 |
9
🐜
|
